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16RESEARCH ARTICLE Open AccessSpider phobia is associated with decreased left
amygdala volume: a cross-sectional study
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Dominique J-F de Quervain3 and Leila M Soravia1Abstract
Background: Evidence from animal and human studies imply the amygdala as the most critical structure involved
in processing of fear-relevant stimuli. In phobias, the amygdala seems to play a crucial role in the pathogenesis and
maintenance of the disorder. However, the neuropathology of specific phobias remains poorly understood. In the
present study, we investigated whether patients with spider phobia show altered amygdala volumes as compared
to healthy control subjects.
Methods: Twenty female patients with spider phobia and twenty age-matched healthy female controls underwent
magnetic resonance imaging to investigate amygdala volumes. The amygdalae were segmented using an
automatic, model-based segmentation tool (FSL FIRST). Differences in amygdala volume were investigated by
multivariate analysis of covariance with group as between-subject factor and left and right amygdala as dependent
factors. The relation between amygdala volume and clinical features such as symptom severity, disgust sensitivity,
trait anxiety and duration of illness was investigated by Spearman correlation analysis.
Results: Spider phobic patients showed significantly smaller left amygdala volume than healthy controls. No
significant difference in right amygdala volume was detected. Furthermore, the diminished amygdala size in
patients was related to higher symptom severity, but not to higher disgust sensitivity or trait anxiety and was
independent of age.
Conclusions: In summary, the results reveal a relation between higher symptom severity and smaller left amygdala
volume in patients with spider phobia. This relation was independent of other potential confounders such as the
disgust sensitivity or trait anxiety. The findings suggest that greater spider phobic fear is associated with smaller left
amygdala. However, the smaller left amygdala volume may either stand for a higher vulnerability to develop a
phobic disorder or emerge as a consequence of the disorder.
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Specific phobias are characterized by automatic, exaggerated
fear responses towards phobia-specific objects [1]. Conver-
ging evidence implies the amygdala as the most critical
structure involved in processing of phobia-relevant, but also
general threatening stimuli [2-6]. Through its broad
connections to other brain areas, it might be involved in me-
diating automatic responses to potential danger [7]. Due to
its projections to the visual stream, it is further likely to* Correspondence: melanie.fisler@puk.unibe.ch
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reproduction in any medium, provided the ormodulate sensory processing [8]. In contrast to large func-
tional imaging evidence for the involvement of the amygdala
in fear, there have been few reported studies on its structural
abnormality in mood and anxiety disorders [9-12]. Reduced
amygdala volume (AMV) has been reported to be signifi-
cantly correlated with the severity of distortion in anxiety
[13,14] and panic disorder [15]. Structural brain imaging
studies in specific phobia are lacking. This raises the ques-
tion whether functional differences in phobic patients ap-
pear in association with structural differences. Because of
evidence of hyperactivity and structural differences in anx-
iety disorders, we hypothesized that also spider phobic
patients (SP) express reduced AMV compared to healthyd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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of physiological and behavioral components. In order to
clarify the contribution of possible confounding factors, sev-
eral aspects of phobic disorders that could be critical to the
pathogenesis have to be considered. Anxiety-related person-
ality traits have been suggested to represent important pre-
disposing factors for anxiety-related disorders [16,17]. Other
potential moderating variables may be the severity and dur-
ation of the disease and disgust sensitivity. Therefore, the as-
sociation between AMV and several clinical features has
been investigated in this study. To the best of our know-
ledge, this is the first study investigating volumetric
differences of the amygdala in SP compared to healthy con-
trol subjects.
Methods
Subjects
Twenty female patients with a current diagnosis of spider
phobia and twenty healthy female controls matched for age
were included in the analysis. Subjects were recruited via
advertisements. The data used for this report has been
collected in a larger project investigating the effect of corti-
sol on the outcome of an exposure-based short-term group
therapy for spider phobia. Because the study design included
an exposure task and in order to minimize motion artifacts,
only patients that could keep still while facing a picture of a
spider were included in the magnetic resonance paradigm.
Exclusion criteria for patients were the following: any axis I
other than specific phobia for spiders, axis II disorders, the
manifestation of acute or chronic medical condition, neuro-
logical diseases, current drug or alcohol abuse or any contra-
indication to magnetic resonance imaging (metallic objects,
pregnancy) or confounding factors for structural brain stud-
ies (regular medication, contraceptives, left handedness).
Healthy control subjects were excluded from the study if
they met any of the following exclusion criteria: axis I-
disorders (measured with the SCL-90-R), the manifestation
of acute or chronic medical condition, neurological diseases,
current drug or alcohol abuse or any contraindication to
magnetic resonance imaging (metallic objects, pregnancy)
or confounding factors for structural brain studies (regular
medication, contraceptives, left handedness). Informed writ-
ten consent was obtained from all participants after descrip-
tion of the study, which was approved by the ethics
committee of the Canton of Bern, Switzerland (161/07) in
accordance with the principles of the Declaration of Helsinki
[18]. Written informed consent was obtained from the pa-
tient for publication of this report and any accompanying
images. A copy of the written consent is available for review
by the Editor-in-Chief of this journal.
Diagnostic instruments and questionnaires
Patients: Diagnoses for specific phobia for spider was
based on the Diagnostic and Statistical Manual of MentalDisorders, fourth edition (DSM-IV) [1]. Specifically, we
used a computer-based structured clinical interview (DIA-
X) [19] which is based on the Composite International
Diagnostic Interview (CIDI) [20]. Patients were screened
for possible axis II disorders, respectively personality ac-
centuation using SKID-II-questionnaire [21]. The SKID-II
is an efficient, user-friendly instrument that helps to make
standardized, reliable, and accurate diagnoses of the 10
DSM-IVAxis II personality disorders.
Control subjects: SCL-90-R was used as short screening
to exclude Axis-I disorders (such as anxiety disorders and
depression) in the control subjects [22].
All subjects filled out the German version of the
Spider Phobia Questionnaire (SPQ) [23] and a question-
naire for the assessment of disgust sensitivity (FEE) [24].
The SPQ is a validated self-report questionnaire widely
used for assessing spider phobic symptom severity. It
consists of 31 items which could be answered by “true”
or “false” statements. Subjects with a SPQ (range 0-31)
score of less than 21 “true” statements were treated as
healthy controls. The FEE is a further development of
the English Disgust Scale [25]. It is used to measure in-
dividual differences in sensitivity to disgust, and to
examine the relationships among different kinds of dis-
gust. Humans with a high disgust sensitivity show longer
and more intensive disgust reactions than those with
lower disgust sensitivity. Disgust sensitivity is treated as
a vulnerability factor for the development and mainten-
ance of disorders such as phobias. Participants had to
rate how disgusted they feel when confronted with sev-
eral stimuli on a five-points Likert-scale (0 = ‘not
disgusting at all’ to4 = ‘very disgusting’). A total score
(range: 0–148) can be calculated which captures a meas-
ure for overall disgust sensitivity towards disgust-
eliciting stimuli. State (both groups) and trait anxiety
(only in patient group) were measured using the German
version of the State-Trait Anxiety Inventory (STAI) [26].
The STAI consists of two 20-item scales for measuring
the anxiety intensity as an emotional state and individual
differences in anxiety proneness as a personality trait.
The STAI state reports the intensity of anxiety feelings
at the moment of assessment. Responses to the STAI
trait items requests subjects to indicate how they gener-
ally feel. Both scales range from 20 to 80 points. Hand-
edness was assessed via the Edinburgh Handedness
Inventory (EHI) [27].
Data acquisition
Magnetic resonance imaging was performed on a 3 T
Siemens Magnetom Trio Scanner (Erlangen, Germany)
equipped with a standard radio-frequency head coil. For
structural images, a high-resolution 3D T1-weighted im-
aging protocol (modified driven equilibrium Fourier trans-
form, MDEFT [28]) was used, resulting in 176 sagittal
Figure 1 Segmentation sample. Example of the automatic
amygdala segmentation with FSL_FIRST of one patient (red) and
one control subject (blue): coronal, saggital, and axial views of the
automatically set boundaries.
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(FOV), and a matrix size of 256×256, resulting in a voxel
size of 1x1x1mm. Further scan parameters were 7.92 ms
repetition time (TR) 2.48 ms echo time (TE) and 910 ms
inversion time (Ti) for an optimal contrast-to-noise ratio
(see [28]). Subjects were measured within their luteal phase
of their menstrual cycle, because a study in healthy female
subjects revealed an increase in AMV during the premen-
strual phase compared to the late follicular phase [29].
Segmentation of the amygdala
For subcortical segmentation, a fully-automated segmen-
tation method (FSL FIRST; http://fsl.fmrib.ox.ac.uk/fsl/
fslwiki/) was used [30], which has been shown to accur-
ately segment subcortical structures [31]. The reliability
for the segmentation of the amygdala by FIRST has been
demonstrated and was correlated with those of manual
tracing [32]. It is based on multivariate Gaussian shape/ap-
pearance models, which are constructed from a large set
of manually labeled and segmented images (336 brains)
from the Center for Morphometric Analysis (MGH,
Boston) and uses a Bayesian framework that includes
intra- and inter-structural variability. Using T1 images, the
segmentation was performed with two stage affine trans-
formation to standard space of MNI152 at 1 mm reso-
lution. The first stage was a standard 12 degrees of
freedom registration to the MNI152 template after which
the normalization has been checked manually. The second
stage applied 12 degrees of freedom registration using an
MNI152 amygdala mask to exclude voxels outside this
subcortical region. The segmented images were then used
to produce mesh and volumetric outputs with boundary
correction. Voxels exhibiting ambiguous structural
characteristics, which are usually located at the borders
between adjacent structures (partial volume effect), were
classified as boundary voxels. The algorithm for the
boundary correction requires the number of modes of
variation (iterations) as input, which was set to 80 for the
amygdalae (as recommended by Patenaude and colleagues
[33]). The vertex information was then automatically
transformed back to native space using the inverse trans-
formation matrix where the boundaries were corrected.
Finally, the summary images of the segmentation outputs
were checked for quality and registration. Samples for the
automatic segmentation of FIRST are shown in Figure 1.
Brain volume measurement
To correct for variations in individual’s head size, the
measured AMV were divided by the total intracranial
volume (ICV). For each subject, the ICV was measured
applying the software tool “BET” (Brain extraction tool)
[34], provided as part of the FSL software distribution.
The extracted voxels were then summed up to provide
an estimate of the ICV.Statistical analysis
SPSS 19 software (SPSS Inc., Armonk, NY) was employed
for statistical analyses. The following tests were used for
the statistical analyses: two-sample independent t-tests to
compare differences between groups for demographic,
clinical and for brain volume variables; relative amygdala
volume values (corrected for ICV) were used for the
multifactorial ANCOVA with group as between-subject
factor and left and right amygdala as the dependent
factors; for the association between AMV and clinical
features, we computed Spearman correlations and
Wilcoxon’s test was applied for comparisons of variables
which were not normally distributed (SPQ and STAI state
pre). In order to check whether the data is normally
distributed, the Mauchly-Test of Sphericity was applied.
The effects of BMI and age on AMV were examined with
separate regression analyses with BMI or age as independ-
ent variables and left or right amygdala volume as
dependent variables. For all statistical analyses, p values of
<.05 (two-sided) were considered as significant results.
Results
Demographic and psychological measures
Patients and control subjects did not differ significantly
with respect to any demographic variables (Table 1). The
age of the subjects ranged from 20 to 54 years with a
mean of 29.9 years in patient group (SD ± 11.3) and 27.1 -
years in control group (SD± 5.9). Group analysis revealed
that patients showed significant higher mean scores
on the SPQ (W=214.5, Z= -5.30, p=0.00). Furthermore,
patients reported higher state anxiety (STAI-state) before
scanning (which included also exposure to spiders;
W= 211.00, Z= -1.97, p= 0.05), but not after scanning
(F [3,36]= 6.32; p= 0.25), suggesting patients suffering
from anticipatory anxiety.
Table 1 Demographic and clinical characteristics of the patients and their control group
Patients (n=20) Controls (n=20)
Characteristics Mean SD Mean SD df t p Equality ofvariance
Age (years) 29.9 11.3 27.1 5.9 38 −0.98 0.33 0.91
Age at onset 6.65 3.28 ————— ————— ————— ————— ————— ——————
Duration of illness (years) 22.14 13.01 ————— ————— ————— ————— ————— —————
Handedness scores 9.7 0.58 9.8 0.41 38 0.65 0.52 0.98
SPQ 21.55 4.29 6.1 3.83 38 −11.99 0.00 0.00
FEE 85.3 22.93 73 26.42 38 −1.47 0.15 0.17
STAI state pre / post scanning 39.85/ 34.85 10.67/ 12.9 32.5/ 30.53 4.05/ 6.61 38 −2.51/ -1.18 0.05/ 0.24 0.05/ 0.54
STAI trait 44.8 6.89 ————— ————— ————— ————— ————— —————
BMI 21.8 3.90 21.63 2.31 38 −1.18 0.87 0.61
SPQ: Spider Phobia Questionnaire; FEE: disgust sensitivity scale; BMI: body mass index.
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Multifactorial ANCOVA of AMV, adjusted for ICV,
showed approximately 13% smaller AMV in patients on
the left than in controls, resulting in a significant between
group effect for left AMV (F [3,36]= 6.39; p= 0.02;
Figure 2a). Separate regression analyses indicated that the
difference in left AMV between patients and controls were
not accounted for by differences in age (F= 1.72; df= 36,
p=0.20) and BMI (F= 0.55, df= 36, p= 0.47). There was no
significant difference of right AMV between patients and
controls (F [3,36] = 2.28; p= 0.20; Figure 2b). Within the
whole group, SPQ scores were negatively correlated with
left AMV (r=-0.47; p=0.005; Figure 3). Separate regression
analyses showed that smaller left amygdala occurred inde-
pendently of age (r=-0.046; p=0.79) and BMI (r=-0.143;
p=0.42). Correlations between left amygdala and the dis-
gust score (FEE) or state anxiety (STAI trait/state) did
not reach significance, nor were there any significantFigure 2 Amygdala volumes of spider phobic patients and healthy co
quartiles, with the median represented by the line. The whiskers extend fro
range (IQR). Circles represent the outliers over 3 IQR below the 25th or abo
following formula: 100x(absolute amygdala volume in mm2/intracranial vol
b: boxplot comparing relative right amygdala volume.correlations between right AMV and clinical scores within
the whole sample. Within the phobic sample, trait anxiety
did not correlate with AMV. Thus, differences in AMV
did not appear to be due to age or BMI or clinical features
of the participants.Discussion
The purpose of this study was to determine whether there
is evidence for AMV differences in patients with spider
phobia compared to healthy controls. As hypothesized,
the findings confirm a reduction in left AMV of patients.
Furthermore, the reduced left AVM is associated with the
severity of spider phobic symptoms. Our finding of abnor-
mal left AMV in patients are consistent with findings that
report diminished amygdala size in fear and anxiety-
related disorders [10,35-40]. We suggest that the auto-
matic manifestation of fear responses is mediated by antrols. The central box shows the data between 25th and 75th
m the upper and lower quartiles to a distance of 1.5 interquartile
ve the 75th quartile. Relative amygdala volumes were calculated by the
ume in mm2). a: boxplot comparing relative left amygdala volume;
Figure 3 Relation between the amygdalae and Spider Phobia Questionnaire (SPQ) scores. A: The scores on the SPQ are negatively
correlated with the left amygdala volume (r=-0.425, p=0.011). More phobic symptoms are found in individuals who have smaller left amygdala.
B: The volumes of the right amygdala are not significantly correlated with SPQ Scores.
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amygdala deficiency.
However, the differences of AMV could be also
influenced by clinical factors. The present findings show
an association between left AMV and symptom severity in
phobic patients in the way that the smaller the left amyg-
dala, the more phobic symptoms they reported. This
finding seems to be attributed to spider phobia, because
we selected patients with pure spider phobia without any
comorbidities and no other potential confounding factor
has shown to be associated with this volume reduction in
spider phobic patients. It is worth remarking that findings
of smaller left AMV, as reported in this study, suggest that
abnormal functioning of this structure may underlie the
symptoms of automatic and exaggerated fear response
observed in specific phobias, as measured with the SPQ,
which reliably assesses fear of spiders [41,42].
Hemispheric differences in amygdala alterations found
in this study may potentially be in line with different
roles in emotion processing for the left and right amyg-
dala which has been found in several studies investigat-
ing mood and anxiety disorders [39,43]. Based on these
studies, it is assumed that the left amygdala is more
involved in processing sustained stimulus evaluation
while the right one is more involved in rapid and undif-
ferentiated processing of emotional stimuli [44].
Some limitations of the present study need to be
mentioned. We only studied female subjects; therefore the
results cannot be generalized to men. We should further
mention the different diagnostic measurements for the
control and patient group. The patient group was add-
itionally screened for possible personality disorders
(SKID-II) and trait-anxiety (STAI-trait). Whereas the con-
trol subjects were only screened for possible axis
I-disorders (SCL-90-R) which implied exclusion of the
study. Additionally, the sample size was modest andshould be extended. However, the patient group can be
considered to be homogenous, as patients did not suffer
from any other axis I disorders at the time of assessment.
Hence, future investigations should include comparisons
of amygdala morphology in various types and degrees of
phobic disorders for a better pathophysiological distinc-
tion. Longitudinal and pre-post treatment studies should
clarify the meaning of the observed amygdala differences
over time.
Conclusion
Still, the reasons for volumetric differences are so far
largely unclear. Two possible interpretations might be
offered: First, smaller left AMV might be a vulnerability
factor for the development of spider phobia. The second
interpretation relates to experience or exposure-related
structural modifications within the amygdala. Whether
the observed atrophy of the amygdala in mood and anx-
iety disorders is progressive and already present at time of
disease onset or develops as a result of damage secondary
to higher amygdala activity is a matter of debate [45,46].
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